High prevalence of NSAID enteropathy as shown by a simple faecal test - Wikidata - wikimedia - TriplyDB

High prevalence of NSAID enteropathy as shown by a simple faecal test

High prevalence of NSAID enteropathy as shown by a simple faecal test

http://www.wikidata.org/entity/Q35356796

about

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis Fecal calprotectin in inflammatory bowel disease Disease monitoring in inflammatory bowel disease The Role of Laboratory Tests in Crohn's Disease Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs Misoprostol therapeutics revisited.Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based survey.Exercise-induced splanchnic hypoperfusion results in gut dysfunction in healthy men.Ileitis: when it is not Crohn's disease Muscovite is protective against non-steroidal anti-inflammatory drug-induced small bowel injury.Utility of neutrophil Fcγ receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease.Biomarkers in inflammatory bowel diseases: current status and proteomics identification strategies.Inflammatory bowel disease and spondylarthropathy.Non-invasive investigation of inflammatory bowel disease.Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?Soluble ST2: a new and promising activity marker in ulcerative colitis.Impact of diets with a high content of greaves-meal protein or carbohydrates on faecal characteristics, volatile fatty acids and faecal calprotectin concentrations in healthy dogs Determining small bowel integrity following drug treatment.Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.Non-steroidal anti-inflammatory drugs as a risk factor for acute diarrhoea: a case crossover study Experimental peritonitis induced by oral administration of indomethacin in Mongolian gerbils.MR enterography to evaluate sub-clinical intestinal inflammation in children with spondyloarthritis.Rebamipide suppresses diclofenac-induced intestinal permeability via mitochondrial protection in mice.The G.U.T. of gut.The influence of a short-term gluten-free diet on the human gut microbiome.Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity Laboratory markers in IBD: useful, magic, or unnecessary toys?Utility of faecal calprotectin analysis in adult inflammatory bowel disease.Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis Fecal Calprotectin in Healthy Children Aged 1-4 Years.The Pig PeptideAtlas: A resource for systems biology in animal production and biomedicine.Differential diagnosis between functional and organic intestinal disorders: is there a role for non-invasive tests?The microbiota-derived metabolite indole decreases mucosal inflammation and injury in a murine model of NSAID enteropathy.Calprotectin as a diagnostic tool for inflammatory bowel diseases Fecal Calprotectin, Elastase, and Alpha-1-Antitrypsin Levels After Roux-en-Y Gastric Bypass; Calprotectin Is Significantly Elevated in the Majority of Patients.Myths and facts in the use of anti-inflammatory drugs.Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use.

P2860

Q24608254-A9E6E328-F456-46A5-B98A-C67676A93CC7 Q26766527-A3C352CD-A92E-4EF9-9B07-02633E253590 Q26777553-E0CAF1C4-6919-48FC-974D-318D333B7004 Q28075045-AD49CB0C-FF94-4014-9741-420FB0B33516 Q28200864-3FDFA666-31FD-4EB6-85BE-0275C3E4D125 Q28361605-3581865B-2A07-4103-8D31-6FE74EFFD377 Q31975938-406C69AA-E7A3-4EBC-8544-F42311D925C0 Q33810083-7E29EDC4-E770-4427-B561-A9A661359606 Q33979860-AE87B8A5-2D77-43EA-8361-0B4EE5DB4134 Q34037331-ACDD4F6A-33D1-498C-97A9-E79EE4CFA75C Q34067974-6C6BB6B4-A384-48C7-AAAF-A481658F3B7D Q34117832-E881E2FD-A0F6-4E4E-8337-38067301E246 Q34413480-5D790FF3-D876-4E91-AFB2-C1D3579E334E Q34474693-EFD440AB-407D-4EE5-B2C8-07B38D5B66E6 Q34512083-FD231FAF-B096-465E-8EC1-3E8B8B6DC816 Q34538353-E6AA7122-3512-4D0D-BB13-509C2F693FFC Q34565398-E5583686-DAAB-45B7-BBB8-DE02A9D73A27 Q34975712-AE00518D-136F-4B70-90F6-78364D0BB4C7 Q35012591-A15720B2-4B2A-4DE3-8998-825AFE519521 Q35200057-8AB9C76D-2540-4AB0-B0B7-3528FA5FA774 Q35364831-ABE4840A-BAD1-4B3A-A110-67E81A28839D Q35598326-3244CDC0-39B0-4EA8-AD8E-7692E90F6744 Q35622330-CE92C7A8-4655-434E-8F53-08734980F420 Q35797727-99FED85B-E357-420F-AB67-696E45A1E40D Q35813196-DCB9E111-16D7-4573-B107-D5C6C9769FBB Q35932416-C1774A60-160C-4758-9BFF-2201A330528C Q35996496-69AD3F64-D2D8-4457-BE14-326072D6A8F7 Q36002388-D129C14E-7163-4A82-92E1-2C4CECD235E9 Q36394876-AE9CCF25-9D08-46DA-9846-1D1A3859C2DA Q36461010-D0B23072-274B-406D-889E-4CFD9225D4FA Q36652430-9B5D39A0-6391-45C5-A482-DBA3FAE8CA5A Q36659252-29FEE6A2-FFE0-47F6-8EA0-E7BD448F723B Q36674401-410F502C-A0F4-4177-AF99-AC36BE128667 Q36709455-CDB2EFDF-EEAB-4080-B413-A624199B1FE4 Q37082691-66D4747C-11A6-459D-BD21-B1053E8828F5 Q37288649-57044777-7C85-46A2-9497-F37592C60B47 Q37427387-0DD5AB0C-1231-48C0-8C2F-EE467E159665 Q37476911-95ABB5D1-42BA-4B32-AD07-09669C1D0410 Q37581340-405B48DC-A79E-4E53-9CB7-A19FFDF44550 Q37618733-9CF651E9-0615-4F58-88CF-D8E48C98C2BF

P2860

High prevalence of NSAID enteropathy as shown by a simple faecal test

http://www.wikidata.org/entity/Q35356796

description

1999 nî lūn-bûn

@nan

1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

High prevalence of NSAID enteropathy as shown by a simple faecal test

@ast

High prevalence of NSAID enteropathy as shown by a simple faecal test

@en

type

label

High prevalence of NSAID enteropathy as shown by a simple faecal test

@ast

High prevalence of NSAID enteropathy as shown by a simple faecal test

@en

prefLabel

High prevalence of NSAID enteropathy as shown by a simple faecal test

@ast

High prevalence of NSAID enteropathy as shown by a simple faecal test

@en

P1433

Q35356796-C0FFAD69-31FD-4A04-B870-A53F475CF376

P1476

Q35356796-07DF1F1E-E58B-483D-AF18-BAD9A8915CFB

P2093

Q35356796-26FACBD6-BB81-4527-BEF9-6648A5623FF9

Q35356796-2EBE6B45-27FD-4BDF-AA30-CB9B0D39A4F8

Q35356796-3D3D3901-D7F8-4792-8D79-91095F38E238

Q35356796-6F7B375B-6045-4BC3-9FAC-52A1BD2AF08E

Q35356796-8E08A3FD-183F-44B0-A3C0-15265DF68015

Q35356796-98CDA50D-7F9A-4C65-A22B-CE6F7CEC7C5E

Q35356796-D686C7BF-D975-4AD5-B247-A95129EC2CE1

P2860

Q35356796-06EB6A95-BA25-4DDE-A8AA-292381CCCA75

Q35356796-0932D505-BAC4-492D-A8EB-1AF13D652579

Q35356796-1B445EA0-3CDF-4A07-8AEB-03E1B5D95D27

Q35356796-3CF52FE0-992E-43F9-9590-D0FCA2E4F47C

Q35356796-411CB512-62D1-4DED-9411-03E42AEDEA03

Q35356796-5FF42107-3922-4B78-8BE2-D6BAADAC70F9

Q35356796-68891CD5-51A6-4AE0-A713-B28D9D55730D

Q35356796-91C87E86-A7E1-4011-8F93-95888B3A8D63

Q35356796-95A0CCFA-6EBB-41F0-AA0F-F65C4375BD8B

Q35356796-9CE61271-F344-4D78-A074-A848D63C321C

P304

Q35356796-74D3F1D9-CFCA-4684-9D6B-EB714C8ED642

P31

Q35356796-194E0E36-BFC0-4BAA-A0CC-0F4AE33E01D7

P356

Q35356796-D06711C6-4001-493A-8815-D0086D2EF995

P407

Q35356796-E38FA47E-CEC7-45F6-A8D3-87C4E731E163

P433

Q35356796-EF871381-E94D-4F5F-B6F0-09CA5B2DA417

P478

Q35356796-8D91290D-0AC2-4DE6-A92F-CC5BBD399278

P577

Q35356796-8492B77F-6746-46C8-B902-8C3F63903EE6

P5875

Q35356796-83673016-E5EE-4A59-8053-80BFB4277F82

P698

Q35356796-C02EC726-6F81-4FDB-A8C3-09C370DEAA5A

P921

Q35356796-E1EE9B73-E34D-4194-8E10-E41ACCD9CE1E

P932

Q35356796-4FABEB4C-92E5-4662-B27F-AF89A314F16C

P356

P1433

P1476

High prevalence of NSAID enteropathy as shown by a simple faecal test

@en

P2093

Bjarnason I

http://www.w3.org/2001/XMLSchema#string

Fagerhol MK

http://www.w3.org/2001/XMLSchema#string

Foster R

http://www.w3.org/2001/XMLSchema#string

Roseth A

http://www.w3.org/2001/XMLSchema#string

Scott D

http://www.w3.org/2001/XMLSchema#string

Sigthorsson G

http://www.w3.org/2001/XMLSchema#string

Tibble JA

http://www.w3.org/2001/XMLSchema#string

P2860

Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test

Comparison of leukocyte excretion and blood loss in inflammatory disease of the bowel.

Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man

Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy.

Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage.

Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration

Ileocolonoscopic findings in seronegative spondylarthropathies.

The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis.

Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and review of the literature.

Non-steroidal anti-inflammatory drugs: how do they damage the gut?

P304

362-366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.45.3.362

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

1999-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12853925

http://www.w3.org/2001/XMLSchema#string

P698

10446103

http://www.w3.org/2001/XMLSchema#string

P921

P932

1727647

http://www.w3.org/2001/XMLSchema#string